Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Intellia Therapeutics, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $107 Billion
- Q1 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 21,458 shares of NTLA stock, worth $199,988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,458
Previous 17,293
24.08%
Holding current value
$199,988
Previous $201,000
24.38%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NTLA
# of Institutions
344Shares Held
98.4MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$121 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$100 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$89.4 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$42 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$35.4 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $708M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...